LL-37 Peptide: Unveiling its Structure, Antimicrobial Power, and Therapeutic Potential
Discover the groundbreaking human cathelicidin peptide, LL-37, a cornerstone of innate immunity with potent antimicrobial and regenerative capabilities for diverse therapeutic breakthroughs.
Get a Quote & SampleUnlocking the Core Value of LL-37 Antimicrobial Peptide

LL-37 Antimicrobial Peptide
LL-37 is the unique human cathelicidin antimicrobial peptide, a critical component of our innate immune system. Renowned for its broad-spectrum defense capabilities, this powerful peptide targets and neutralizes a wide array of pathogens, making it a pivotal asset in advanced therapeutic developments and cutting-edge research.
- Explore the intricate human cathelicidin LL-37 structure and its unique mechanism of action against bacterial membranes.
- Discover the broad-spectrum LL-37 antimicrobial peptide mechanism, effective against bacteria, fungi, and viruses.
- Understand the diverse LL-37 peptide therapeutic applications, from innate immunity modulation to advanced wound care.
- Benefit from the high purity LL-37 peptide for reliable research and pharmaceutical development.
Key Advantages of LL-37 for Advanced Applications
Potent Broad-Spectrum Antimicrobial Action
NINGBO INNO PHARMCHEM CO.,LTD. offers LL-37 with remarkable broad-spectrum antimicrobial activity, crucial for fighting infections across various biological systems. Its ability to disrupt microbial membranes makes it an invaluable asset.
Crucial Immune System Modulation
As a vital innate immunity modulator, LL-37 exhibits significant chemotactic and immunostimulatory effects, bolstering host defenses against pathogens and contributing to a robust immune response.
Promising Regenerative and Anti-biofilm Properties
Its unique characteristics include potent LL-37 wound healing properties and the ability to effectively inhibit bacterial biofilms, making it invaluable for medical innovations and challenging clinical scenarios.
Key Applications
Infectious Disease Management
LL-37 is a critical component in antimicrobial peptide therapeutics development, offering a new frontier in combating drug-resistant pathogens and enhancing traditional antibiotic efficacy.
Advanced Wound Care
Recognized for its LL-37 wound healing properties, this peptide accelerates tissue repair and reduces infection risk in complex injuries, supporting regenerative medicine.
Immunology & Inflammatory Conditions
Research into innate immunity modulators research highlights LL-37's role in regulating immune responses, particularly in conditions like rosacea and psoriasis, offering novel treatment pathways.
Biopharmaceutical & Research Solutions
High purity LL-37 raw peptide serves as an essential component for drug discovery, clinical trials, and fundamental biological research, driving innovation in life sciences.